Grant: Project Grant
Research Institute of the McGill University Health Centre
$1,243,126.00
Unraveling how de novo germline H3.3 mutations promote neurodegeneration and disease
EF 2023-24
Résumé
In the intricate world of our DNA, a group of special proteins known as histones ensure that our genes are read accurately - like playing the right tune in a song. These histones are essential, guiding when and where genes activate, whether it's for a baby or an adult, a skin cell or a brain cell.
A recent breakthrough unveiled 63 mutations in histones among patients facing severe
neurological challenges. These individuals struggle to achieve basic milestones such as
walking and speaking. Some also grapple with aggressive behaviors and seizures that disrupt their daily lives.
These mutations are rare yet immensely significant, given histones' pivotal role in life. Our
team has made headway in revealing how a specific change in one part of a histone's
structure triggers neuroinflammation and subsequent neurodegeneration. We're now on a
quest to decipher why a different mutation in the same part of the histone tail causes an
entirely distinct disease, impacting other tissues and leading to issues like morbid obesity,
kidney and liver problems, and musculoskeletal dysfunctions. We're also investigating two
nearby mutations that result in separate brain disorders - one marked by cognitive difficulties and aggressive behavior, and the other by microcephaly and severe neurodegeneration.
Our findings indicate that many of these histone mutations alter how DNA can be accessed. Proper histone function relies on modifications, but in these mutated histones, this process goes awry. Using cutting-edge molecular and biochemical analyses, growing tiny brain-like structures called "3D organoids," and using engineered mouse models, we will uncover how these mutations contribute to brain dysfunction and disease, and pinpoint affected genes that could respond to therapy.
Our discoveries will serve as a foundation for new treatments, not only for children grappling with severe brain conditions but also for those battling life-threatening cancers driven by histone mutations.
Programme
Project Grant
Emplacement
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
499698
Name
Jabado Nada
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Cell Biology - Disease
Projecttitle
Unraveling how de novo germline H3.3 mutations promote neurodegeneration and disease
Programtype2
Operating Grants
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$1,243,126
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Dna Methylation; Genetically Modified Animals; Histone Marks; Muscular Dystrophy; Neurobehavioural; Neurodevelopment; Obesity; Organoids; Urinary Tract Dysfunction
Abstract
In the intricate world of our DNA, a group of special proteins known as histones ensure that our genes are read accurately - like playing the right tune in a song. These histones are essential, guiding when and where genes activate, whether it's for a baby or an adult, a skin cell or a brain cell.
A recent breakthrough unveiled 63 mutations in histones among patients facing severe
neurological challenges. These individuals struggle to achieve basic milestones such as
walking and speaking. Some also grapple with aggressive behaviors and seizures that disrupt their daily lives.
These mutations are rare yet immensely significant, given histones' pivotal role in life. Our
team has made headway in revealing how a specific change in one part of a histone's
structure triggers neuroinflammation and subsequent neurodegeneration. We're now on a
quest to decipher why a different mutation in the same part of the histone tail causes an
entirely distinct disease, impacting other tissues and leading to issues like morbid obesity,
kidney and liver problems, and musculoskeletal dysfunctions. We're also investigating two
nearby mutations that result in separate brain disorders - one marked by cognitive difficulties and aggressive behavior, and the other by microcephaly and severe neurodegeneration.
Our findings indicate that many of these histone mutations alter how DNA can be accessed. Proper histone function relies on modifications, but in these mutated histones, this process goes awry. Using cutting-edge molecular and biochemical analyses, growing tiny brain-like structures called "3D organoids," and using engineered mouse models, we will uncover how these mutations contribute to brain dysfunction and disease, and pinpoint affected genes that could respond to therapy.
Our discoveries will serve as a foundation for new treatments, not only for children grappling with severe brain conditions but also for those battling life-threatening cancers driven by histone mutations.
Competitiondate
202403
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Jabado, Nada
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $1,243,126~ $0~